advertisement
Ophthalmology and therapy 13
Showing records 1 to 13 | Display all abstracts in Ophthalmology and therapy77043 Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma
Agrawal P
Ophthalmology and therapy 2018; 7: 49-73
76464 The Role of Diet in Glaucoma: A Review of the Current Evidence
Al Owaifeer AM
Ophthalmology and therapy 2018; 7: 19-31
76900 The Correlation Between Aqueous Humor Flow and IOP Before and After Trabectome: Developing a Grading System to Quantify Flow
Ueda T
Ophthalmology and therapy 2018; 7: 133-143
76975 A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzo
Gómez-Aguayo F
Ophthalmology and therapy 2018; 7: 145-156
76464 The Role of Diet in Glaucoma: A Review of the Current Evidence
Al Taisan AA
Ophthalmology and therapy 2018; 7: 19-31
76975 A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzo
Paczka JA
Ophthalmology and therapy 2018; 7: 145-156
77043 Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma
Bradshaw SE
Ophthalmology and therapy 2018; 7: 49-73
76900 The Correlation Between Aqueous Humor Flow and IOP Before and After Trabectome: Developing a Grading System to Quantify Flow
Suzumura H
Ophthalmology and therapy 2018; 7: 133-143
76975 A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzo
Leñero-Córdova R
Ophthalmology and therapy 2018; 7: 145-156
76900 The Correlation Between Aqueous Humor Flow and IOP Before and After Trabectome: Developing a Grading System to Quantify Flow
Johnstone M; Uda S
Ophthalmology and therapy 2018; 7: 133-143
76975 A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzo
Jiménez-Román J; Davila-Villarreal J
Ophthalmology and therapy 2018; 7: 145-156
76900 The Correlation Between Aqueous Humor Flow and IOP Before and After Trabectome: Developing a Grading System to Quantify Flow
Yoshida K
Ophthalmology and therapy 2018; 7: 133-143
76975 A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzo
Hartleben C; Baiza-Durán L; Olvera-Montaño O; García-Velez F; Muñoz-Villegas P
Ophthalmology and therapy 2018; 7: 145-156
